Page results
-
UCLH Charity is delighted to announce that the Dangoor Family’s Exilarch’s Foundation has pledged a £1.2m gift to support the next phase of the development of the CAR T programme at University College London Hospitals NHS Foundation Trust (UCLH). The CAR T Speed Release Project aims to reduce the time between extracting patient’s stem cells and injecting re-engineered CAR T cells back into patients with cancer to fight cancer cells.
-
Tens of thousands of people in England who have hepatitis C could now get tested and treated thanks to a new mobile health unit arriving to coincide with World Hepatitis Day on 28 July.
-
Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs in a trial at UCLH.
-
Neurological complications of COVID-19 can include delirium, brain inflammation, stroke and nerve damage, finds a new UCL and UCLH-led study.
-
Alison Clements, head of operations, patient flow and EPRR, has received a medal in recognition of her work to support NHS preparations for the Coronation of Charles III and Camilla last May.
-
UCLH will be part of a major UK research study looking at the long-term health impacts of COVID-19.
-
A second mass vaccination event will be held over four days this month at Emirates Stadium in a bid to give thousands more people the chance to have their first or second dose of the Pfizer Covid-19 vaccine.
-
The Clinical and Research Informatics Unit at UCLH consists of a team of clinicians, researchers, software developers, business intelligence analysts and data scientists working together to develop a robust environment for the analysis of clinical data.
-
Patient information who have been recommended to use a Biatain® dressing on your skin that has broken down due to your radiotherapy or proton beam therapy treatment.
-
A new NHS vaccination centre at UCL’s Bidborough House, Bidborough Street, WC1H 9BT opened 26 August 2021.
File results
-
FOI/2023/0187 - Treatment for urothelial and colorectal cancer
-
FOI/2023/0182 - Data privacy compliance tools
-
FOI/2023/0180 - Treatment guidelines for chronic kidney disease/ diabetic kidney disease
-
FOI/2023/0175 - Treatment for Myelofibrosis
-
FOI/2023/0139 - Meningitis and Encephalitis guidelines/ pathway
-
FOI/2023/0143 - Immunoassay Analysers at Trust
-
FOI/2023/0142 - Treatment of breast cancer
-
FOI/2023/0145 - Waiting times for consultant-led treatment, inpatient and outpatients
-
FOI/2023/0138 - Subject Access Requests (SARs) and Freedom of Information Requests
-
FOI/2023/0132 - Renal cell carcinoma and melanoma treatment